AIM: Semaphorin 3A urinary levels represent an early, predictive biomarker of acute kidney injury and positively correlate with albumin-to-creatinine ratio and serum creatinine in hypertensive patients with chronic kidney disease. Our purpose has been to evaluate semaphorin 3A serum levels in a cohort of haemodialysis (HD) patients, the influence of a single HD session on its concentrations, and the potential correlation with clinical and biochemical parameters. METHODS: We enrolled 18 patients receiving HD with Acetate-Free Biofiltration technique and 16 healthy subjects as controls. Peripheral venous blood samples were obtained from patients at different intervals: start of dialysis (pre-HD), middle, and end of the treatment (post-HD). We also collected dialysate samples by the Quantiscan monitoring system (Hospal, Bologna, Italy). RESULTS: Semaphorin 3A was significantly lower in HD patients at baseline compared to controls (median 19.50 (interquartile range 1.00-65.00) versus 97.50 (23.50-161.00) ng/mL, P = 0.0237). A statistically significant reduction was seen during a single HD session (from 19.50 (1.00-65.00) to 0.86 (0.82-4.21) ng/mL, P < 0.0001), with a reduction ratio of 65.92 ± 33.51%. The median concentration in dialysate was 54.00 (15.00-102.00) ng/mL. Pre-HD values were directly related to serum vitamin D (r = 0.872; P = 0.001) and inversely correlated with calcium levels (r = -0.426; P = 0.012) and calcium × phosphate product (r = -0.422; P = 0.0252). CONCLUSION: Semaphorin 3A removal during HD may be clinically relevant due to its involvement in different aspects of cell physiology and in bone remodelling. Semaphorin 3A both inhibits osteoclastic bone reabsorption and increases osteoblastic new bone formation, thus playing a dual osteoprotective role.
Xu Ren, Semaphorin 3A : A new player in bone remodeling, 10.4161/cam.27752
Tillo Miguel, Ruhrberg Christiana, Mackenzie Francesca, Emerging roles for semaphorins and VEGFs in synaptogenesis and synaptic plasticity, 10.4161/cam.22408
Reidy Kimberly, Tufro Alda, Semaphorins in kidney development and disease: modulators of ureteric bud branching, vascular morphogenesis, and podocyte-endothelial crosstalk, 10.1007/s00467-011-1769-1
Villegas Guillermo, Tufro Alda, Ontogeny of semaphorins 3A and 3F and their receptors neuropilins 1 and 2 in the kidney, 10.1016/s0925-4773(03)00108-4
Vadasz Z, Ben-Izhak O, Bejar J, Sabo E, Kessel A, Storch S, Toubi E, The involvement of immune semaphorins and neuropilin-1 in lupus nephritis, 10.1177/0961203311417034
Jayakumar Calpurnia, Ranganathan Punithavathi, Devarajan Prasad, Krawczeski Catherine D., Looney Stephen, Ramesh Ganesan, Semaphorin 3A Is a New Early Diagnostic Biomarker of Experimental and Pediatric Acute Kidney Injury, 10.1371/journal.pone.0058446
Doi Kent, Noiri Eisei, Nangaku Masaomi, Yahagi Naoki, Jayakumar Calpurnia, Ramesh Ganesan, Repulsive guidance cue semaphorin 3A in urine predicts the progression of acute kidney injury in adult patients from a mixed intensive care unit, 10.1093/ndt/gft414
Viazzi Francesca, Ramesh Ganesan, Jayakumar Calpurnia, Leoncini Giovanna, Garneri Debora, Pontremoli Roberto, Increased urine semaphorin-3A is associated with renal damage in hypertensive patients with chronic kidney disease: a nested case–control study, 10.1007/s40620-014-0097-5
Tsim T.Y, Wong E.Y.K, Leung M.S, Wong C.-C, Expression of axon guidance molecules and their related genes during development and sexual differentiation of the olfactory bulb in rats, 10.1016/j.neuroscience.2003.10.024
Vadasz Zahava, Haj Tharwat, Halasz Katalin, Rosner Itzhak, Slobodin Gleb, Attias Dina, Kessel Aharon, Kessler Ofra, Neufeld Gera, Toubi Elias, Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus, 10.1186/ar3881
Vadasz Zahava, Toubi Elias, Semaphorins: Their Dual Role in Regulating Immune-Mediated Diseases, 10.1007/s12016-013-8360-4
Reidy K. J., Villegas G., Teichman J., Veron D., Shen W., Jimenez J., Thomas D., Tufro A., Semaphorin3a regulates endothelial cell number and podocyte differentiation during glomerular development, 10.1242/dev.037267
Ranganathan P., Jayakumar C., Mohamed R., Weintraub N. L., Ramesh G., Semaphorin 3A inactivation suppresses ischemia-reperfusion-induced inflammation and acute kidney injury, 10.1152/ajprenal.00177.2014
Reidy Kimberly J., Aggarwal Pardeep K., Jimenez Juan J., Thomas David B., Veron Delma, Tufro Alda, Excess Podocyte Semaphorin-3A Leads to Glomerular Disease Involving PlexinA1–Nephrin Interaction, 10.1016/j.ajpath.2013.06.022
Bondeva Tzvetanka, Rüster Christiane, Franke Sybille, Hammerschmid Elke, Klagsbrun Michael, Cohen Clemens D., Wolf Gunter, Advanced glycation end-products suppress neuropilin-1 expression in podocytes, 10.1038/ki.2008.603
Zhang Licheng, Zhang Lihai, Mao Zhi, Tang Peifu, Semaphoring 3A: An association between traumatic brain injury and enhanced osteogenesis, 10.1016/j.mehy.2013.07.034
Yamashita Teruhito, New roles of osteoblasts involved in osteoclast differentiation, 10.5312/wjo.v3.i11.175
Fukuda Toru, Takeda Shu, Xu Ren, Ochi Hiroki, Sunamura Satoko, Sato Tsuyoshi, Shibata Shinsuke, Yoshida Yutaka, Gu Zirong, Kimura Ayako, Ma Chengshan, Xu Cheng, Bando Waka, Fujita Koji, Shinomiya Kenichi, Hirai Takashi, Asou Yoshinori, Enomoto Mitsuhiro, Okano Hideyuki, Okawa Atsushi, Itoh Hiroshi, Sema3A regulates bone-mass accrual through sensory innervations, 10.1038/nature12115
Cernaro Valeria, Santoro Domenico, Lucisano Silvia, Nicocia Giacomo, Lacquaniti Antonio, Buemi Michele, The future of phosphate binders: a perspective on novel therapeutics, 10.1517/13543784.2014.962652
Cernaro, Ital. J. Anat. Embryol., 118, 98 (2013)
Bielesz Bernhard O., Hempfing Till, Kieweg Heidi, Marculescu Rodrig, Haas Martin, Cejka Daniel, Sclerostin Declines during Hemodialysis and Appears in Dialysate, 10.1159/000364992
Bibliographic reference
Cernaro, Valeria ; Lucisano, Silvia ; Buemi, Antoine ; Visconti, Luca ; Lacava, Viviana ; et. al. Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance?. In: Nephrology, Vol. 20, no.4, p. 236-242 (2015)